The top 15 holdings make up 41.82% of the Fund.
| Top holdings |
Sector allocation |
(%) |
| AbbVie Inc |
Drugs |
3.33% |
| AstraZeneca PLC |
Drugs |
3.23% |
| Eli Lilly and Co |
Drugs |
3.20% |
| Bristol-Myers Squibb Co |
Drugs |
2.94% |
| Vertex Pharmaceuticals Inc |
Drugs |
2.90% |
| Roche Holding AG - Partcptn |
Drugs |
2.85% |
| Pfizer Inc |
Drugs |
2.72% |
| BioNTech SE - ADR |
Drugs |
2.67% |
| CRISPR Therapeutics AG |
Drugs |
2.65% |
| Thermo Fisher Scientific Inc |
Healthcare Equipment |
2.59% |
| Johnson & Johnson |
Drugs |
2.57% |
| Genscript Biotech Corp |
Drugs |
2.57% |
| Novartis AG Cl N |
Drugs |
2.55% |
| Merck & Co Inc |
Drugs |
2.55% |
| Beam Therapeutics Inc |
Drugs |
2.50% |